Literature DB >> 27056150

Newly-Recognized Roles of Factor XIII in Thrombosis.

James R Byrnes1, Alisa S Wolberg1.   

Abstract

Arterial and venous thromboses are major contributors to coagulation-associated morbidity and mortality. Greater understanding of mechanisms leading to thrombus formation and stability is expected to lead to improved treatment strategies. Factor XIII (FXIII) is a transglutaminase found in plasma and platelets. During thrombosis, activated FXIII cross-links fibrin and promotes thrombus stability. Recent studies have provided new information about FXIII activity during coagulation and its effects on clot composition and function. These findings reveal newly-recognized roles for FXIII in thrombosis. Herein, we review published literature on FXIII biology and effects on fibrin structure and stability, epidemiologic data associating FXIII with thrombosis, and evidence from animal models indicating FXIII has an essential role in determining thrombus stability, composition, and size. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27056150      PMCID: PMC5680043          DOI: 10.1055/s-0036-1571343

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  108 in total

1.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.

Authors:  Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

2.  Coagulation factor XIIIa is inactivated by plasmin.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Heidi M Britton; James R Byrnes; Alisa S Wolberg; Christian J Kastrup
Journal:  Blood       Date:  2015-09-10       Impact factor: 22.113

3.  Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.

Authors:  Amir-Houshang Shemirani; Bálint Antalfi; Endre Pongrácz; Zoltán András Mezei; Zsuzsanna Bereczky; Zoltán Csiki
Journal:  Blood Coagul Fibrinolysis       Date:  2014-06       Impact factor: 1.276

Review 4.  Thrombin generation and fibrin clot structure.

Authors:  Alisa S Wolberg
Journal:  Blood Rev       Date:  2007-01-08       Impact factor: 8.250

5.  A photometric assay for blood coagulation factor XIII.

Authors:  K Fickenscher; A Aab; W Stüber
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

6.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

7.  Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.

Authors:  S A Shaya; L J Saldanha; N Vaezzadeh; J Zhou; R Ni; P L Gross
Journal:  J Thromb Haemost       Date:  2016-01-04       Impact factor: 5.824

8.  Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.

Authors:  Camilla Lund Nikolajsen; Thomas F Dyrlund; Ebbe Toftgaard Poulsen; Jan J Enghild; Carsten Scavenius
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

9.  Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke.

Authors:  D Martijn O Pruissen; Arjen J C Slooter; Frits R Rosendaal; Yolanda van der Graaf; Ale Algra
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

10.  Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function.

Authors:  Cédric Duval; Peter Allan; Simon D A Connell; Victoria C Ridger; Helen Philippou; Robert A S Ariëns
Journal:  Thromb Haemost       Date:  2014-01-16       Impact factor: 5.249

View more
  30 in total

1.  Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.

Authors:  Lauren R Schmitt; Rachel Henderson; Alexander Barrett; Zsuzsanna Darula; Aaron Issaian; Angelo D'Alessandro; Nathan Clendenen; Kirk C Hansen
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

Review 2.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 3.  New findings on venous thrombogenesis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Hamostaseologie       Date:  2016-11-23       Impact factor: 1.778

4.  Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

Authors:  L G Poole; A Pant; K S Baker; A K Kopec; H M Cline-Fedewa; S E Iismaa; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2018-12-10       Impact factor: 5.824

Review 5.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

6.  Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.

Authors:  Madhavi A Jadhav; Whitney N Goldsberry; Sara E Zink; Kelsey N Lamb; Katelyn E Simmons; Carmela M Riposo; Boris A Anokhin; Muriel C Maurer
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-07-04       Impact factor: 3.036

7.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

8.  The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.

Authors:  Sravya Kattula; Zsuzsa Bagoly; Noémi Klára Tóth; László Muszbek; Alisa S Wolberg
Journal:  J Thromb Haemost       Date:  2020-02-28       Impact factor: 5.824

9.  Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.

Authors:  Lauren G Poole; Anna K Kopec; Dafna J Groeneveld; Asmita Pant; Kevin S Baker; Holly M Cline-Fedewa; Matthew J Flick; James P Luyendyk
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

10.  Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in Hypercoagulability.

Authors:  Huriye Ercan; Lisa-Marie Mauracher; Ella Grilz; Lena Hell; Roland Hellinger; Johannes A Schmid; Florian Moik; Cihan Ay; Ingrid Pabinger; Maria Zellner
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.